Source: Burgess DS. Antimicrobial
Regimen Selection. In: DiPiro, JT, Talbert RL, Yee GC, Matzke GR, Wells
BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. 8 ed. http://accesspharmacy.com/content.aspx?aid=8001114.
Accessed June 23, 2012.
- “Empiric” regimen: initiated before
offending organism is identified and sometimes prior to documentation
of presence of infection.
- “Definitive” regimen: instituted when causative
organism is known.
- Obtain careful history and physical.
- Signs and Symptoms
temperature above normal range of 36.7–37°C
(98.1–98.6°F; measured orally)
- Hallmark of infectious disease
- May be caused by drugs in absence of infection or other underlying
- Elevated white blood cell (WBC) count
and/or lymphocytes are mobilized to destroy invading microbes.
- Bacterial infections associated with
granulocyte counts (neutrophils and basophils)
- Increased band neutrophils in peripheral smear (left-shift)
- Low neutrophil counts (neutropenia), indicating abnormal response;
associated with poor prognosis
- Tuberculosis, viral, or fungal infections associated with
relative lymphocytosis even with normal or slightly elevated total
- Local signs
- Pain and inflammation
- Purulent drainage
- Collect infected body material.
with Gram stain.
- Perform blood cultures and sensitivities.
- Perform serologic tests for presence of antibodies.
- Collect suspected fluids or tissues (e.g., spinal fluid in
- Assess inflammation with deep-seated infections by examining
tissues or fluids (e.g., examine sputum to assess pneumonia).
- Factors to consider
- Severity and acuity
- Local susceptibility data rather than national compilations
- Host factors
- Allergy or history of adverse
- Age of patient
- Metabolic abnormalities
- Renal and hepatic function: Adjust dosage with diminished
renal and/or hepatic function to avoid drug accumulation.
- Concomitant drug therapy: Potential for drug interactions
- Concomitant disease states
- Drug factors
- Use generally accepted drugs
based on pathogen (Table 2)
- Consider pharmacokinetic and pharmacodynamic properties of
- Bactericidal effects may be concentration-dependent
(aminoglycosides and fluoroquinolones) or time-dependent (β-lactams).
- Treatment outcome can be predicted by area under concentration-time
curve (AUC) and maximal plasma concentration.
- Duration that drug concentration exceeds minimal inhibitory
concentration (MIC) is most important pharmacodynamic relationship
for antimicrobials that display time-dependent bactericidal effects.
- Antibiotic tissue penetration varies with site of infection.
- Clinically relevant drug concentrations found in blood,
urine, synovial fluid, and peritoneal fluid.
- Combination therapy should be considered to:
the spectrum of coverage for empiric therapy
when multiple aerobic and anaerobic bacteria are likely to be present
(e.g., in intraabdominal and female pelvic infections)
- Achieve synergistic activity against infecting organism
- Advantageous for infections caused by gram-negative bacilli
in immunosuppressed patients.
- May produce better results in infections caused by Pseudomonas aeruginosa and certain
infections caused by Enterococcus spp.
- Prevent the emergence of resistance
Table 1. Major Drug Interactions with Antimicrobials |Favorite Table|Download (.pdf)
Table 1. Major Drug Interactions with Antimicrobials
Mechanism of Action/Effect
Neuromuscular blocking agents
Additive adverse effects
Nephrotoxins (N) or ototoxins (O) (e.g., amphotericin
B (N) cisplatin (N/O), cyclosporine ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessPharmacy Full Site: One-Year Subscription
Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.
Pay Per View: Timed Access to all of AccessPharmacy
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.